Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARCADE: Predictors of Depression Response to Citalopram in ACS Patients
NCT01099592Phase 4Terminated
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Nov 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of citalopram in major depressive disorder (MDD), sponsored by Centre hospitalier de l’Université de Montréal. Started Nov 2010; status: terminated.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01099592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01099592.